Report suggests ‘promising’ M&A landscape in healthtech

Almost 100 mergers and acquisitions in the healthtech sector were made in the second half of 2018 according to a report from advisor Hampleton Partners.

Transaction volume remained steady compared to the first half of 2018, declining by 6%, remaining in line with a stable trend since 2013. The trailing 30-month revenue multiple rose again to 2.8x Enterprise Value-to-Sales (EV/S), prolonging a trend visible over the last 18 months, since the increase to 2.8x in the second half of 2017 from a lower 2.1x EV/S in the first half 2017.

In 2018, 186 healthcare companies went public, bringing aggregate gross IPO proceeds for the year to $24 billion, up from only $15 billion in 2017.

The largest disclosed deals in the second half of 2018 included Veritas Capital and Evergreen Coast Capital’s joint private equity acquisition of athenahealth for $5.7 billion, at an attractive 17.3x EV/EBITDA. Athenahealth provides electronic healthcare record management SaaS for hospitals and healthcare practices in the U.S.

Second, at $1 billion, came the acquisition of M*Modal by 3M. M*Modal provides clinical documentation, transcription and EHR SaaS for the medical sector.

Dutch tech and health giant Philips remains the sector’s most consistently active acquirer, with a total of seven acquisitions over the past 30 months, including Blue Willow Systems and its tracking and alert-based systems for senior living facilities.

Jonathan Simnett, director and healthtech specialist at Hampleton Partners, said: “The rise of lifestyle diseases, an ageing population and higher patient expectations are compelling both public and private healthcare systems to incorporate technology to improve productivity, cost-efficiency and patient satisfaction.”

M&A activity is now featuring in the medical marijuana sector, following regulatory changes in 10 U.S. states and Washington D.C. In November, cannabis network marketing website Leafbuyer Technologies acquired Greenlight Technologies, a cannabis ordering and rewards mobile application. The app includes features such as loyalty programmes and real-time customer data analytics. Such acquisitions are likely to become more frequent across the US as regulations continue to evolve.

Key trends in healthtech:

  • Established technology companies such as Amazon, Samsung and Cisco are looking for synergies and ways to enter the healthtech sector.

Key examples of this trend include Amazon’s acquisition of online pharmacy service PillPack for $1 billion earlier in 2018, and Samsung’s current collaboration with Stanford University and start-up Syncthink to study the use of VR in establishing concussion severity. In addition, Cisco is working with GE Healthcare and Philips to provide the network support for device connection, security and data integration in healthcare.

  • Self-service tech, such as health-monitoring software, drug-tracking apps or remote consultation interfaces, is generating interest amongst strategic and financial acquirers.
  • All eyes are on data, especially as blockchain continues to disrupt the market with new ways of storing, securing and managing medical data
  • The move to the cloud continues, with SaaS healthtech companies driving innovation for public and private health practices

Jonathan Simnett said: “The M&A landscape in healthtech remains promising. Big tech companies are entering the healthcare sector and healthcare professionals are keen to adopt technology that makes everything from transcribing patient notes, to diagnosis and treatment more effective and cost-efficient. New markets are being created by millions of consumers now monitoring their own health via apps and online programmes at home and on-the-go and by medical marijuana deregulation.

“Patient-oriented self-service healthtech billing and payment management, SaaS, EHR patient data and medical records systems will remain in particularly high demand by buyers, along with emerging blockchain applications which can improve the security and traceability of patient data, pharmaceuticals and surgical equipment.”



About


'Report suggests ‘promising’ M&A landscape in healthtech' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions